NNP
AVNS icon

Nachman Norwood & Parrott’s Avanos Medical AVNS Stock Holding History

Nachman Norwood & Parrott’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-604
Closed -$20K – 325
2020
Q3 		$20K Buy
+604
New +$19.3K ﹤0.01% 618

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nachman Norwood & Parrott's AVNS Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Avanos Medical (AVNS) in Q4 2020, closing a stake of 604 shares — an estimated $20K sold.

Nachman Norwood & Parrott first reported a position in AVNS in Q3 2020 and held it in 1 quarter. The position peaked at $20K in Q3 2020. 281 funds tracked by Wall St. Rank hold AVNS as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Avanos Medical position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 604 Avanos Medical shares in Q4 2020, an estimated $20K.
  • Nachman Norwood & Parrott first reported a position in Avanos Medical in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Avanos Medical position peaked at $20K in Q3 2020.
  • 281 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.